Detalhe da pesquisa
1.
Grandmaster level in StarCraft II using multi-agent reinforcement learning.
Nature
; 575(7782): 350-354, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31666705
2.
Single-cell transcriptome analysis reveals subtype-specific clonal evolution and microenvironmental changes in liver metastasis of pancreatic adenocarcinoma and their clinical implications.
Mol Cancer
; 23(1): 87, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38702773
3.
Mirikizumab: A New Therapeutic Option for the Treatment of Ulcerative Colitis.
Ann Pharmacother
; : 10600280241229742, 2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38344998
4.
Etrasimod: A Sphingosine-1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis.
Ann Pharmacother
; : 10600280231225770, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38258760
5.
Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn's Disease.
Dig Dis Sci
; 69(2): 355-359, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112840
6.
Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center.
Dig Dis Sci
; 69(2): 579-587, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38087126
7.
Description of Roseibium sediminicola sp. nov. Isolated from Sediment of a Tidal Flat on the Yellow Sea Coast.
Curr Microbiol
; 81(6): 150, 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38647555
8.
Constructing local cell-specific networks from single-cell data.
Proc Natl Acad Sci U S A
; 118(51)2021 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34903665
9.
Risankizumab Effectiveness and Safety in Crohn's Disease: Real-world Data From a Large Tertiary Center.
Clin Gastroenterol Hepatol
; 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38065372
10.
Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data From a Large Tertiary Center.
Clin Gastroenterol Hepatol
; 21(9): 2407-2409.e2, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35381385
11.
Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World Experience.
Clin Gastroenterol Hepatol
; 21(7): 1913-1923.e2, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36898598
12.
Multidisciplinary consensus guideline for the diagnosis and management of spontaneous intracranial hypotension.
J Neurol Neurosurg Psychiatry
; 94(10): 835-843, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37147116
13.
Evaluation of prior authorizations in transplant recipients at an urban institution.
Clin Transplant
; 37(6): e14964, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36940175
14.
Risankizumab-rzaa: A New Therapeutic Option for the Treatment of Crohn's Disease.
Ann Pharmacother
; 57(5): 579-584, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214282
15.
Evaluating the Incidence and Risk Factors for Acute Cellular Rejection in a Steroid Sparing Liver Transplant Center.
Ann Pharmacother
; 57(5): 553-559, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36004388
16.
Cell-cell adhesion impacts epithelia response to substrate stiffness: Morphology and gene expression.
Biophys J
; 121(2): 336-346, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34864047
17.
The use of non-transplant biologics in solid organ transplant recipients: A practical review for the frontline clinician.
Clin Transplant
; 36(7): e14743, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35690919
18.
Ozanimod: A First-in-Class Sphingosine 1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis.
Ann Pharmacother
; 56(5): 592-599, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34423657
19.
Adalimumab-Adbm: The First Interchangeable Biosimilar for the Treatment of Inflammatory Diseases.
Ann Pharmacother
; 56(12): 1356-1364, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35392668
20.
Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center.
Transpl Infect Dis
; 24(4): e13867, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35604549